514 related articles for article (PubMed ID: 24225276)
21. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.
Chen P; Lin JJ; Lu CS; Ong CT; Hsieh PF; Yang CC; Tai CT; Wu SL; Lu CH; Hsu YC; Yu HY; Ro LS; Lu CT; Chu CC; Tsai JJ; Su YH; Lan SH; Sung SF; Lin SY; Chuang HP; Huang LC; Chen YJ; Tsai PJ; Liao HT; Lin YH; Chen CH; Chung WH; Hung SI; Wu JY; Chang CF; Chen L; Chen YT; Shen CY;
N Engl J Med; 2011 Mar; 364(12):1126-33. PubMed ID: 21428768
[TBL] [Abstract][Full Text] [Related]
22. HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.
Amstutz U; Ross CJ; Castro-Pastrana LI; Rieder MJ; Shear NH; Hayden MR; Carleton BC;
Clin Pharmacol Ther; 2013 Jul; 94(1):142-9. PubMed ID: 23588310
[TBL] [Abstract][Full Text] [Related]
23. HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
Park HJ; Kim YJ; Kim DH; Kim J; Park KH; Park JW; Lee JH
Yonsei Med J; 2016 Jan; 57(1):118-26. PubMed ID: 26632391
[TBL] [Abstract][Full Text] [Related]
24. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.
Zhang Y; Wang J; Zhao LM; Peng W; Shen GQ; Xue L; Zheng XX; He XJ; Gong CY; Miao LY
Eur J Clin Pharmacol; 2011 Sep; 67(9):885-7. PubMed ID: 21424386
[TBL] [Abstract][Full Text] [Related]
25. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
[TBL] [Abstract][Full Text] [Related]
26. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
[TBL] [Abstract][Full Text] [Related]
27. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children.
Manuyakorn W; Siripool K; Kamchaisatian W; Pakakasama S; Visudtibhan A; Vilaiyuk S; Rujirawat T; Benjaponpitak S
Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241
[TBL] [Abstract][Full Text] [Related]
28. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.
Hung SI; Chung WH; Jee SH; Chen WC; Chang YT; Lee WR; Hu SL; Wu MT; Chen GS; Wong TW; Hsiao PF; Chen WH; Shih HY; Fang WH; Wei CY; Lou YH; Huang YL; Lin JJ; Chen YT
Pharmacogenet Genomics; 2006 Apr; 16(4):297-306. PubMed ID: 16538176
[TBL] [Abstract][Full Text] [Related]
29. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.
Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Chen P; Lin SY; Chen WH; Konyoung P; Khunarkornsiri U; Auvichayapat N; Pavakul K; Kulkantrakorn K; Choonhakarn C; Phonhiamhan S; Piyatrakul N; Aungaree T; Pongpakdee S; Yodnopaglaw P
Epilepsia; 2010 May; 51(5):926-30. PubMed ID: 20345939
[TBL] [Abstract][Full Text] [Related]
30. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.
Cheung YK; Cheng SH; Chan EJ; Lo SV; Ng MH; Kwan P
Epilepsia; 2013 Jul; 54(7):1307-14. PubMed ID: 23692434
[TBL] [Abstract][Full Text] [Related]
31. Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti-seizure medications.
Mullan KA; Anderson A; Shi YW; Ding JH; Ng CC; Chen Z; Baum L; Cherny S; Petrovski S; Sham PC; Lim KS; Liao WP; Kwan P
Epilepsia; 2022 Apr; 63(4):936-949. PubMed ID: 35170024
[TBL] [Abstract][Full Text] [Related]
32. HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis.
Khor AH; Lim KS; Tan CT; Wong SM; Ng CC
Epilepsia; 2014 Nov; 55(11):e120-4. PubMed ID: 25266342
[TBL] [Abstract][Full Text] [Related]
33. A study of HLA-B*15:02 in 9 different Chinese ethnics: Implications for carbamazepine related SJS/TEN.
Ou GJ; Wang J; Ji X; Yu H; Jiang L; Li L; Chen Q; Su PC; Liu Z
HLA; 2017 Apr; 89(4):225-229. PubMed ID: 28205426
[TBL] [Abstract][Full Text] [Related]
34. Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?
Shi YW; Min FL; Qin B; Zou X; Liu XR; Gao MM; Wang Q; Zhou JQ; Liao WP
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):58-64. PubMed ID: 22348435
[TBL] [Abstract][Full Text] [Related]
35. HLA alleles and drug hypersensitivity reactions.
Profaizer T; Eckels D
Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
[TBL] [Abstract][Full Text] [Related]
36. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
37. Genetic screening for human leukocyte antigen alleles prior to carbamazepine treatment.
Tan JC; Murrell DF; Hersch MI
J Clin Neurosci; 2015 Dec; 22(12):1992-3. PubMed ID: 26319500
[TBL] [Abstract][Full Text] [Related]
38. Association of Human Leukocyte Antigen Alleles with Carbamazepine- or Lamotrigine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in an Iranian Population: A Case-control Study.
Dastgheib L; Rostami F; Gharesi-Fard B; Asadi-Pooya AA; Namjoo S; Tahmasebi F; Hadibarhaghtalab M
Iran J Med Sci; 2023 Jan; 48(1):70-76. PubMed ID: 36688194
[TBL] [Abstract][Full Text] [Related]
39. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
[TBL] [Abstract][Full Text] [Related]
40. A marker for Stevens-Johnson syndrome ...: ethnicity matters.
Lonjou C; Thomas L; Borot N; Ledger N; de Toma C; LeLouet H; Graf E; Schumacher M; Hovnanian A; Mockenhaupt M; Roujeau JC;
Pharmacogenomics J; 2006; 6(4):265-8. PubMed ID: 16415921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
